glp-1/gip dual agonist lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating Glucose-dependent insulinotropic polypeptide receptor signaling
Pay in 4 interest-free payments of $7.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8

















